To make sure you don't miss another HSI e-Alert, please confirm your free subscription with one simple click.

October 08, 2008 Why am I getting this?
The hushed-up truth about DMSO

And the new pain breakthrough that's 12 ways more powerful

Twenty years ago, 60 Minutes showcased this “pain miracle” to 70 million viewers, and The New York Times hailed it in a lead editorial. Then it virtually disappeared from the halls of healthcare. WHY?

See inside for the shocking truth, and the new breakthrough that…


Dear Reader,

Q: What might be nearly as dangerous as a chronic disease that often leads to respiratory failure?

A: The drugs used to treat the disease.

Q: Is there a safer alternative treatment that most mainstream doctors probably don't even know about?

A: Absolutely.

Dire risks

As I've noted in past e-Alerts, chronic obstructive pulmonary disease (COPD) is an umbrella term that refers to emphysema, chronic bronchitis, asthma, or any combination of the three. There's no cure for this long-term deterioration of the respiratory system, but proper treatments can slow the decline.

COPD is the fourth leading cause of death in the U.S. According to the World Health Organization, almost three million patients die of COPD-related complications each year, but a 2003 review of more than 300,000 UK death certificates concluded that that the actual yearly toll may be closer to five million.

A new study raises a disturbing question: Could COPD medications actually add to that yearly toll?

The study appeared last month in the Journal of the American Medical Association. Researchers from Wake Forest University School of Medicine screened 17 trials that tested inhaled anticholinergic medication in nearly 15,000 subjects. (More than eight million patients have used inhaled anticholinergics since approval of the drug in 2002.)

Results showed that inhaled anticholinergic use increased the risk of heart attack by more than 50 percent, and increased the risk of cardiovascular death by 80 percent! Risk of stroke was also significantly higher.

Another way to inhale

Stroke. Heart attack. Cardiovascular death. You might be thinking there's got to be a better way, and there is.

In the August 2002 issue of his Nutrition & Healing newsletter, alternative medicine pioneer Jonathan V. Wright, M.D., discussed COPD at length, and stated that nebulized, inhaled glutathione is "the No. 1 natural treatment for COPD in my practice."

E-Alert readers will recognize glutathione as the powerful antioxidant and amino acid molecule that I've written about many times. In Dr. Wright's COPD regimen, glutathione is taken via a nebulizer; an apparatus that dispels liquid in a fine mist to be inhaled.

In a 2005 issue of Health e-Tips, Dr. Wright elaborated: "The best natural treatment for COPD is nebulized, inhaled glutathione, a safe, natural treatment that has helped countless patients with COPD, emphysema, and chronic bronchitis to breathe easier.

"A dose of 120-200 milligrams inhaled twice a day is what I usually recommend. Each day's glutathione should be prepared in its own separate vial since it rapidly loses strength when exposed to air. A compounding pharmacist can prepare it for you with a physician's prescription and can usually supply the nebulizer, too."

Additional steps in Dr. Wright's COPD regimen include Vitamins C and E, magnesium, zinc, N-acteylcysteine, and lecithin – all of which should be administered with the help of an experienced health care professional.

You can find more specific details in the Health e-Tips titled "Package Deal."

Dr. Wright notes that by the time a COPD diagnosis is made, lung tissue is already badly damaged. But he adds, "I can safely say that this type of therapy usually stops and at least partially reverses the progression of the disease. Often, improvement can be quite significant."

Avoid the stop-and-start and...

Pee Like a Firehose!

New findings are so cutting-edge, even your doctor may not have been briefed. This amazing alternative could be the answer to a healthy prostate FAST & FOREVER...keep reading:

To start receiving your own copy of the HSI e-Alert, visit:
Or forward this e-mail to a friend so they can sign-up to receive their own copy of the HSI e-Alert.


....and another thing

The list of health problems linked to cholesterol-lowering statin drugs just got a little longer.

Researchers at the University of Toronto examined the results of surgery in more than 280,000 elderly patients. Their analysis revealed an increased risk of postoperative delirium among those who used statins for at least 90 days prior to surgery.

Risk increased even more in patients over the age of 70 and in patients who underwent longer surgeries.

According to Ivanhoe Newswire, the researchers suggest that patients stop taking statins before surgery, and then (of course!) start taking them again after surgery.

Or…maybe that would be a perfect time to quit.

Earlier this year I told you about a Business Week article titled "Do Cholesterol Drugs Do Any Good?" In that article, James M. Wright, M.D. (director of Therapeutics Initiative, a Canadian organization that reviews the effectiveness of drugs), noted that statin trials show that ANY amount of reduction in LDL cholesterol does not reduce heart attack risk in people over the age of 65, or in women of any age. The two exceptions: Those who have already had a heart attack and those at high risk of heart disease may slightly reduce their risk of heart attack.

Meanwhile, statin use may actually raise the risk of cognitive impairment in elderly patients, which would fit right in with the surgery/delirium connection. You can read further details about the cognitive risks linked to statins in the e-Alert "Your Secret Friend" (8/25/08).

To Your Good Health,

Jenny Thompson

Great sex by next Saturday

Remember firm, spontaneous erections, intense desire, and long-lived stamina that were just a normal part of sex?

You could be experiencing great sex by next Saturday (or even sooner). And even better you can have that hot spontaneous sex you desire naturally. That’s right, no dangerous drugs, no silly tools, and no potentially botched surgeries.

To start receiving your own copy of the HSI e-Alert, visit:
Or forward this e-mail to a friend so they can sign-up to receive their own copy of the HSI e-Alert.


Tap into the minds of other health-conscious readers like yourself at the new HSI health forum:

"Inhaled Anticholinergics and Risk of Major Adverse Cardiovascular Events in Patients With Chronic Obstructive Pulmonary Disease" Journal of the American Medical Association, Vol. 300, No. 12, 9/24/08,
"Officials Call Off Controversial Autism Study" Will Dunham, Reuters, 9/17/08,
"New Statin Risk" Ivanhoe Newswire, 9/24/08,

Copyright (c)2008 by, L.L.C. Thank you for your interest in the Health Sciences Institute of Baltimore. We do not allow republication of our full newsletters and articles. However, you can post a portion (no more than 90 words, 1-2 paragraphs) of our content with a live link back to our homepage (, or a link to the specific article you are quoting from.

Before you hit reply to send us a question or request, please visit here

To learn more about HSI, call (915)849-4614 or visit,

If you want to end your HSI e-Alert subscription or you need to change your e-mail address, please follow the instructions below. Your changes will be effective immediately. However, if you do not follow the instructions below and simply hit reply instead, we may not receive your request and cannot assure you that it will be completed.

Please note: We sent this e-mail to:
because you subscribed to this service.

Manage your subscription:

To end your HSI e-Alert subscription...visit this address:

To change your e-mail address...visit this address:

To manage your subscription by mail or for any other subscription issues, write us at:

Order Processing Center
Attn: Customer Service
P.O. Box 925
Frederick, MD 21705 USA